Tumor-stromal interactions in pancreatic cancer

被引:42
|
作者
Tod, Jo [1 ]
Jenei, Veronika [1 ]
Thomas, Gareth [1 ]
Fine, David [1 ]
机构
[1] Univ Southampton, Sch Med, Canc Sci Unit, Southampton SO16 6YD, Hants, England
基金
英国医学研究理事会;
关键词
Pancreatic cancer; Microenvironment; Tumor stroma; REGULATORY T-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; NERVE GROWTH-FACTOR; STELLATE CELLS; MATRIX SYNTHESIS; CARCINOMA CELLS; E-CADHERIN; STIMULATING PROLIFERATION; OXIDATIVE STRESS; INDUCE FIBROSIS;
D O I
10.1016/j.pan.2012.11.311
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pancreatic adenocarcinoma has one of the worse prognoses of any cancer with a 5-year survival of only 3%. Pancreatic cancer displays one of the most prominent stromal reactions of all tumors and it is evident that this is a key contributing factor to disease outcome. The tumor microenvironment of pancreatic cancer harbors a wide spectrum of cell types and a complex network of mechanisms which all serve to promote tumor progression. It is clear that the symbiotic relationship between pancreatic cancer cells and stellate cells is the chief factor creating this unique tumor milieu. Pancreatic stellate cells play critical roles in evasion of cancer cell apoptosis, invasion and metastases, angiogenesis, and promotion of an immunosuppressive environment, all key hallmarks of malignancy. Existing treatments for pancreatic cancer focus on targeting the cancer cells rather than the whole tumor, of which cancer cells represent a small proportion. It is now increasingly evident that research targeted towards the interactions between these cell types, ideally at an early stage of tumor development, is imperative in order to propel the way forward to more effective treatments. Copyright (C) 2012, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [21] Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction
    Hamada, Shin
    Masamune, Atsushi
    Shimosegawa, Tooru
    FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [22] Tumor-Stromal Co-Dependencies as Actionable Targets in Pancreatic Cancer
    Sangwan, V.
    Ricoult, S.
    Juncker, D.
    Saluja, A.
    Haibe-Kains, B.
    Park, M.
    PANCREAS, 2014, 43 (08) : 1403 - 1404
  • [23] Targeting tumor-stromal interactions in bone metastasis
    Esposito, Mark
    Kang, Yibin
    PHARMACOLOGY & THERAPEUTICS, 2014, 141 (02) : 222 - 233
  • [24] Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions
    Chen, Xin
    Zhang, Yanzhen
    Qian, Weikun
    Han, Liang
    Li, Wei
    Duan, Wanxing
    Wu, Zheng
    Wang, Zheng
    Ma, Qingyong
    ISCIENCE, 2021, 24 (12)
  • [25] The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions
    Sidhu, SS
    Mengistab, AT
    Tauscher, AN
    LaVail, J
    Basbaum, C
    ONCOGENE, 2004, 23 (04) : 956 - 963
  • [26] Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer
    Neumann, Christopher C. M.
    von Hoerschelmann, Ellen
    Reutzel-Selke, Anja
    Seidel, Elisabeth
    Sauer, Igor Maximilian
    Pratschke, Johann
    Bahra, Marcus
    Schmuck, Rosa Bianca
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (05) : 461 - 472
  • [27] Tumor-stromal interactions facilitate polyclonal metastasis
    Kok, Sauyee
    Oshima, Hiroko
    Nakayama, Mizuho
    Oshima, Masanobu
    CANCER SCIENCE, 2024, 115 : 96 - 96
  • [28] Antifibrotic Agent, Pirfenidone, Inhibits Pancreatic Stellate Cells and Tumor-Stromal Interaction in Pancreatic Cancer
    Kozono, S.
    Ohuchida, K.
    Eguchi, D.
    Fujiwara, K.
    Zhao, M.
    Cui, L.
    Mizumoto, K.
    Tanaka, M.
    PANCREAS, 2012, 41 (08) : 1377 - 1377
  • [29] Transcriptomic hallmarks of tumor-stromal interactions in brain metastasis
    Don Nguyen
    FASEB JOURNAL, 2018, 32 (01):
  • [30] SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions
    Sato, N
    Fukushima, N
    Maehara, N
    Matsubayashi, H
    Koopmann, J
    Su, GH
    Hruban, RH
    Goggins, M
    ONCOGENE, 2003, 22 (32) : 5021 - 5030